Cargando…
Effects of iodinated contrast agent on HU-based dose calculation and dose delivered in iridium-192 high-dose-rate brachytherapy
PURPOSE: This study compares the effect of iodinated contrast agent on Hounsfield unit (HU)-based TG-186 dose calculation vs. delivered dose for high-dose-rate (HDR) iridium-192 brachytherapy using a phantom model. MATERIAL AND METHODS: A reservoir filled with a diluted contrast agent was placed ins...
Autores principales: | Scherf, Christian, Ramm, Ulla, Stein, Thomas, Trommel, Martin, Tselis, Nikolaos, Chatzikonstantinou, Georgios, Diefenhardt, Markus, Rödel, Claus, Köhn, Janett, Licher, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867231/ https://www.ncbi.nlm.nih.gov/pubmed/35233239 http://dx.doi.org/10.5114/jcb.2022.113551 |
Ejemplares similares
-
Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view
por: Scherf, Christian, et al.
Publicado: (2021) -
Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach
por: Fleischmann, Maximilian, et al.
Publicado: (2022) -
Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer
por: Chatzikonstantinou, Georgios, et al.
Publicado: (2021) -
Determination of the tissue inhomogeneity correction in high dose rate Brachytherapy for Iridium-192 source
por: Ravikumar, Barlanka, et al.
Publicado: (2012) -
High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
por: Behmueller, Manuel, et al.
Publicado: (2021)